AbbVie, Eli Lilly, UnitedHealth Group, and Johnson & Johnson are major holdings in the XLV ETF and dominate the healthcare sector basket.
2 reports, 1 independent
Updated Aug 7
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AbbVie, Eli Lilly, UnitedHealth Group, and Johnson & Johnson are major holdings in the XLV ETF and dominate the healthcare sector basket.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Keep exploring
The entities involved
-
AbbVie
pharmaceutical company
-
Eli Lilly and Company
American pharmaceutical company
-
UnitedHealth Group
for-profit health care company
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
Related events
- AbbVie, Eli Lilly, and Merck are broadening their therapeutic reach.
- Financial results and stock performance comparisons among AbbVie, Johnson & Johnson, Eli Lilly, and Merck.
- AbbVie and Eli Lilly are competing in the pharmaceutical market.
- Ken Griffin made investment moves on October 18, 2026, buying shares of AbbVie and Abbott Laboratories, and boosting Eli Lilly shares.
- Eli Lilly and Company and Lockheed Martin are mentioned as active market players.